First-in-Human Total-Body PET/CT Imaging Using<sup>89</sup>Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma
We report on a 54-y-old man with stage pT3pN1pM1(HEP) pancreatic-head adenocarcinoma and liver metastasis. After diagnosis 20 mo previously, he underwent Whipple surgery and multiple chemotherapy regimens including folinic acid, fluorouracil, irinotecan hydrochloride, and oxaliplatin; gemcitabine/
Authors
- Tina Brennan
- Harshad Kulkarni (ORCID: https://orcid.org/0000-0001-6164-3163)
- Anthony Chang
- Ryohei Kobayashi (ORCID: https://orcid.org/0000-0001-8364-5354)
- B.R. Mancini (ORCID: https://orcid.org/0000-0002-6207-6129)
- Kevin A. Maupin (ORCID: https://orcid.org/0000-0002-9651-9186)
- Dan Rogers
- Jens Forsberg
- Sreenivasa R Chandana
- Mark W. Olson
Institutions
- Kuyper College (US)
- Grand Rapids Women's Health (US)
- Hematology Oncology Consultants (US)
- Nihon Medi-Physics (Japan) (JP)
- Michigan State University (US)
Publication Details
- Journal
- Journal of Nuclear Medicine
- Published
- 2024-09-05
- DOI
- https://doi.org/10.2967/jnumed.124.268074
- Citations
- 1
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Japan Agency for Medical Research and Development